Weight regain after GLP-1s: A gut procedure’s test
Fractyl Health’s Revita beat a sham procedure on its six-month goal in a pivotal trial, but the FDA’s 12-month bar is the real test. In Fractyl Health’s pivotal trial, everyone regained weight after stopping tirzepatide. The question was how much, and whether a one-time procedure could shrink the nu
<p>Fractyl Health’s Revita beat a sham procedure on its six-month goal in a pivotal trial, but the FDA’s 12-month bar is the real test. In Fractyl Health’s pivotal trial, everyone regained weight after stopping tirzepatide. The question was how much, and whether a one-time procedure could shrink the nu</p>